Trulieve becomes first in state to sell whole-flower smokable cannabis
TALLAHASSEE, FL, March 21, 2019 /CNW/ - Trulieve Cannabis (OTC: TCNNF & CNSX: TRUL) ("Trulieve"), a leading and top performing cannabis company in the United States, was the first medical marijuana licensee in Florida to make a sale of smokable cannabis. The sale took place at Trulieve's Tallahassee dispensary, the first dispensary to have opened in the state.
"We are excited about the opportunity to sell whole flower smokable products to patients in Florida and honored to be the first company in Florida to do so. Thank you to Governor DeSantis and the Legislature for taking up and approving smokable products in Florida and special thanks to the Department of Health and the Office of Medical Marijuana Use for their quick action to make today a reality for patients in need. Offering these whole flower products to our patients in their purest, most effective form is something we – and patients – have been looking forward to since we opened the doors of the state's first dispensary," said Trulieve CEO Kim Rivers.
Dr. Cheryl Fee, a Tallahassee-based physician, was the doctor to make the recommendation. Regarding the ability to recommend smokable cannabis for patients, she stated: "It's an honor to be a part of the first sale and provide patients that need it this smokable whole-flower option."
Trulieve's smokable whole-flower buds will be the first product available and is offered in a rotating selection of popular strains. Trulieve also plans to roll out smokable marijuana in a variety of forms, including pre-roll.
Presently, Trulieve operates 26 dispensaries throughout the state of Florida, spanning from Pensacola to Miami. As part of the company's mission to ensure safe, reliable access for patients statewide, Trulieve plans to continue opening stores statewide as the patient registry and demand grows.
In stores and online, patients will find Florida's largest selection of THC and CBD products, available in a variety of delivery methods, including flower for smoking and vaporizing, concentrates, tinctures, topical creams, vaporizers, and more. Trulieve also offers home delivery statewide for patients unable to make it to a physical store.
Recently, the Office of Medical Marijuana Use announced the registry had surpassed 190,000 registered medical marijuana patients with an active ID card, with Trulieve consistently selling between 60%-80% of the state's overall volume, per the Florida Department of Health. There are currently more than 2,000 registered ordering physicians in the state of Florida as well.
Trulieve Cannabis Corp. is a vertically integrated "seed to sale" company and is the first and largest fully licensed cannabis company in the State of Florida. Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve-branded stores (dispensaries) throughout the State of Florida, as well as directly to patients via home delivery. Trulieve also operates in California and Massachusetts.
Trulieve is listed on the Canadian Securities Exchange under the symbol TRUL.
This press release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or the securities laws of any state of the United States and may not be offered or sold within the United States (as defined in Regulation S under the U.S. Securities Act) unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from such registration requirements.
To learn more about Trulieve, visit www.Trulieve.com.
SOURCE Trulieve Cannabis Corp.
For further information: Kevin Darmody, Director, Investor Relations, (850) 480-7955, [email protected]; Victoria Walker, Director of Marketing & Community Relations, (704) 773-3446, [email protected]